KATHRYN FILIPEK: Open Payments
NPI 1235242975 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,825 in 90 payments from 10 companies in 2025. Trend: 2023 $20,753 · 2024 $1,246 · 2025 $5,825
Speaker / faculty: $3,300Food & beverage: $2,480Travel & lodging: $37Education: $8
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 14 | $3,606 |
| Arcutis Biotherapeutics, Inc. | 18 | $629 |
| Janssen Biotech, Inc. | 7 | $469 |
| ABBVIE INC. | 18 | $259 |
| Organon LLC | 8 | $217 |
| PFIZER INC. | 11 | $180 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $153 |
| UCB, Inc. | 1 | $137 |
| GENZYME CORPORATION | 8 | $135 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
Products named: AKLIEF, Zoryve, TREMFYA, NEMLUVIO, SKYRIZI, DUPIXENT, Bimzelx, Winlevi.
Industry payments across GA — which companies pay providers there.
